# Neuroimaging Study of Risk Factors for Adolescent Bipolar Disorder

> **NCT02478788** · PHASE4 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 153 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** mixed amphetamine salts-extended release (MAS-XR)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02478788
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2022-08
- **Final completion:** 2022-12
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2023-09-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02478788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02478788, "Neuroimaging Study of Risk Factors for Adolescent Bipolar Disorder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02478788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*